Resolutions from Extraordinary General Meeting of Elos Medtech AB (publ) 2021
Elos Medtech held its Extraordinary General Meeting (”EGM”) on 22 December 2021. Due to the ongoing Covid-19 pandemic, the EGM was, pursuant to temporary regulation, carried out through advance voting only, without any physical attendance. The EGM made inter alia the following resolutions:
Determination of the number of Board members
The EGM resolved, in accordance with the proposal from the majority shareholder in Elos Medtech AB, TA Associates through EM Intressenter AB, that the number of ordinary members of the Board of Directors shall be four (previously five) for the period of until the end of the next Annual General Meeting.
Determination of fees to be paid to the Board members
The EGM resolved, in accordance with the proposal from EM Intressenter AB, that the remuneration to the Board of Directors and for committee work until the end of the next Annual General Meeting shall be allocated pursuant to the same principles as resolved upon by the Annual General Meeting 2021, however, no remuneration shall be allocated to Board members that are not independent in relation to EM Intressenter AB and TA Associates.
Election of the Board of Directors
The EGM resolved, in accordance with proposal from EM Intressenter AB, to elect Stefano Alfonsi as new Board member and elect Lovisa Lander as new Chairman of the Board of Directors for the period until the end of the next Annual General Meeting. Chairman of the Board of Directors Yvonne Mårtensson and Board member Jon Risfelt are leaving the Board of Directors at their own request in connection with the EGM. The Board members Birker Bahnsen, Lovisa Lander and Alexander Cicetti remain as Board members until the end of the next Annual General Meeting.
Minutes from the EGM together with complete decisions will be provided at the company’s webpage, www.elosmedtech.com.
For more information, please contact:
Jan Wahlström, CEO and President, 070 212 18 89, jan.wahlstrom@elosmedtech.com
Ewa Linsäter, CFO, 076 633 32 33, ewa.linsater@elosmedtech.com
For more information about the Group Elos Medtech, please see www.elosmedtech.com
Tags: